|
Multiple Sclerosis, Relapsing-Remitting
|
C20.111.258.250.500.600 |
|
|
Adenosine A3 Receptor Agonists
|
D27.505.696.577.725.200.100.300 |
|
|
Psychomotor Disorders
|
C10.597.606.881 |
|
|
Pharmacovigilance
|
E05.337.800.600 |
|
|
Product Surveillance, Postmarketing
|
E05.337.800 |
|
|
Neoplasm Recurrence, Local
|
C23.550.727.655 |
|
|
Laryngocele
|
C08.360.549 |
|
|
NADPH Oxidases
|
D08.811.682.608.575 |
|
|
NADH, NADPH Oxidoreductases
|
D08.811.682.608 |
|
|
Pineal Gland
|
A08.186.211.200.317.200.620 |
|
|
Epithalamus
|
A08.186.211.200.317.200 |
|
|
Knowledge Bases
|
L01.224.050.375.480 |
|
|
Ergoloid Mesylates
|
D03.132.327.412.250.500 |
|
|
Dihydroergotoxine
|
D03.132.327.412.250 |
|
|
Neurocysticercosis
|
C01.610.335.190.902.185.550 |
|
|
Cysticercosis
|
C01.610.335.190.902.185 |
|
|
Repression-Sensitization
|
F01.393.821.645 |
|
|
Repression, Psychology
|
F01.393.821 |
|
|
CD-I
|
L01.280.960.800.250.100 |
|
|
Compact Disks
|
L01.280.960.800.250 |
|
